NasdaqCM:AXGNMedical Equipment
Axogen (AXGN) Q1 Loss Of US$0.38 EPS Tests Bullish Margin Improvement Narrative
Axogen (AXGN) opened 2026 with Q1 revenue of US$61.5 million and a basic EPS loss of US$0.38, alongside a net loss of US$19.6 million. This keeps the focus firmly on how fast the top line can support a path back toward profitability. Over the past five reported quarters, revenue has moved from US$48.6 million in Q1 2025 to US$61.5 million in Q1 2026, while basic EPS has swung between a small profit of US$0.02 and losses, including US$0.08 in Q1 2025 and US$0.38 this quarter. In that context,...